CD8A and pancreatic ductal adenocarcinoma: In support of this conclusion are the findings which demonstrate positive effects of CD8+PD-1+TRM cells after ICB treatment (55, 56), but these CD8+PD-1+TRM cells may be related to a poor prognosis in pancreatic ductal adenocarcinoma and glioblastoma without ICB treatment (57, 58).